Why the study?
Decreasing blood triglyceride levels and proinflammatory factors can alleviate hyperlipidemic acute pancreatitis, prompting the development of dual-modified mesoporous silica nanoparticles to capture IL-6 and decompose triglycerides.
Does a dual-modified mesoporous silica nanoparticle improve IL-6 absorption and triglyceride decomposition in plasma from HAP patients?
Population
Plasma of HAP patients
Comparison
Dual-modified mesoporous silica nanoparticles with IL-6 aptamer and lipase
Design
In vitro experimental study
Follow-up
2 h
Authors
Loading...
Enzyme-powered nanoparticles may lower triglycerides and IL-6 in HAP; leaves open clinical efficacy in patients.
Does a dual-modified mesoporous silica nanoparticle improve IL-6 absorption and triglyceride decomposition in plasma from HAP patients?
Dual-modified mesoporous silica nanoparticles can effectively absorb IL-6 and decompose triglycerides in vitro, suggesting potential utility in an absorption device for treating hyperlipidemic acute pancreatitis.
Chen et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: